{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:08:07Z","timestamp":1790647687190,"version":"4.1.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience & Biobehavioral Reviews"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.neubiorev.2019.09.036","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T11:56:03Z","timestamp":1569844563000},"page":"696-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":204,"special_numbering":"C","title":["How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review"],"prefix":"10.1016","volume":"107","author":[{"given":"Abigail M.","family":"Freeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Petrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandni","family":"Hindocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Mokrysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Valerie","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom P.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.neubiorev.2019.09.036_bib0005","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/BF02085029","article-title":"Interactions of \u03941-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography","volume":"37","author":"Agurell","year":"1981","journal-title":"Experientia"},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0010","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-019-05246-8","article-title":"Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition","author":"Arkell","year":"2019","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0015","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/can.2017.0014","article-title":"Cannabidiol does not dampen responses to emotional stimuli in healthy adults","volume":"2","author":"Arndt","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00213-011-2374-5","article-title":"Psychoactive drugs and false memory: comparison of dextroamphetamine and delta-9-tetrahydrocannabinol on false recognition","volume":"219","author":"Ballard","year":"2012","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2019.09.036_bib0025","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00213-012-2924-5","article-title":"Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans","volume":"226","author":"Ballard","year":"2013","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(98)00392-6","article-title":"An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity","volume":"353","author":"Ben-Shabat","year":"1998","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2019.09.036_bib0035","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2019.09.036_bib0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF00434409","article-title":"Intercannabinoid and cannabinoid-ethanol interactions and their effects on human performance","volume":"71","author":"Bird","year":"1980","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.neubiorev.2019.09.036_bib0045","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pharmthera.2018.10.006","article-title":"The neuropsychopharmacology of cannabis: a review of human imaging studies","volume":"195","author":"Bloomfield","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.neubiorev.2019.09.036_bib0055","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/09540261.2018.1474730","article-title":"Cannabis and cannabinoid drug development: evaluating botanical versus single molecule approaches","volume":"30","author":"Bonn-Miller","year":"2018","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pnpbp.2013.11.017","article-title":"Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or\u0394 9-tetrahydrocannabinol (THC)","volume":"52","author":"Bossong","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0065","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 7: considering bias and conflicts of interest among the included studies","author":"Boutron","year":"2019"},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0070","series-title":"Hopkins Verbal Learning Test-Revised (HVLT-R)","author":"Brandt","year":"2001"},{"issue":"1607","key":"10.1016\/j.neubiorev.2019.09.036_bib0075","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philos. Trans. Biol. Sci."},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00406-019-00983-5","article-title":"New trends in cannabis potency in USA and Europe during the last decade (2008\u20132017)","volume":"269","author":"Chandra","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2019.09.036_bib0085","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s40429-017-0142-2","article-title":"Does cannabis composition matter? Differential effects of delta-9-tetrahydrocannabinol and cannabidiol on human cognition","volume":"4","author":"Colizzi","year":"2017","journal-title":"Curr. Addict. Rep."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2018.07.014","article-title":"Cannabis use and the development of tolerance: a systematic review of human evidence","volume":"93","author":"Colizzi","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0095","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drugalcdep.2013.12.013","article-title":"Investigation of sex-dependent effects of cannabis in daily cannabis smokers","volume":"136","author":"Cooper","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00213-002-1169-0","article-title":"Cognitive and subjective dose-response effects of acute oral \u03949-tetrahydrocannabinol (THC) in infrequent cannabis users","volume":"164","author":"Curran","year":"2002","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.neubiorev.2019.09.036_bib0110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn.2016.28","article-title":"Keep off the grass? Cannabis, cognition and addiction","volume":"17","author":"Curran","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0115","first-page":"1","article-title":"Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?","author":"Curran","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0120","series-title":"Desired and Undesired Effects of Cannabis on the Human Mind and Psychological Well-being. Handbook of Cannabis","first-page":"647","author":"Curran","year":"2014"},{"issue":"4","key":"10.1016\/j.neubiorev.2019.09.036_bib0125","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00213-012-2955-y","article-title":"Cannabidiol enhances consolidation of explicit fear extinction in humans","volume":"226","author":"Das","year":"2013","journal-title":"Psychopharmacology."},{"issue":"8","key":"10.1016\/j.neubiorev.2019.09.036_bib0130","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D\u2019Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"10.1016\/j.neubiorev.2019.09.036_bib0135","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/sj.npp.1301643","article-title":"Blunted psychotomimetic and amnestic effects of \u0394-9-tetrahydrocannabinol in frequent users of cannabis","volume":"33","author":"D\u2019Souza","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2019.09.036_bib0140","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cpt1976193300","article-title":"Influence of cannabidiol on delta-9-tetrahydrocannabinol effects","volume":"19","author":"Dalton","year":"1976","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2-3","key":"10.1016\/j.neubiorev.2019.09.036_bib0145","first-page":"242","article-title":"Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol","volume":"114","author":"Demirakca","year":"2011","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.neubiorev.2019.09.036_bib0150","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/jat\/bkv012","article-title":"Smoked cannabis' psychomotor and neurocognitive effects in occasional and frequent smokers","volume":"39","author":"Desrosiers","year":"2015","journal-title":"J. Anal. Toxicol."},{"issue":"3\u20134","key":"10.1016\/j.neubiorev.2019.09.036_bib0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/17588928.2018.1504764","article-title":"Alcohol and pharmacologically similar sedatives impair encoding and facilitate consolidation of both recollection and familiarity in episodic memory","volume":"9","author":"Doss","year":"2018","journal-title":"Cogn. Neurosci."},{"issue":"8","key":"10.1016\/j.neubiorev.2019.09.036_bib0160","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S2215-0366(17)30075-5","article-title":"Can we make cannabis safer?","volume":"4","author":"Englund","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"J. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.neubiorev.2019.09.036_bib0170","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/cpt1973146936","article-title":"Impairment of performance with low doses of marihuana","volume":"14","author":"Evans","year":"1973","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0175","series-title":"How Does Cannabidiol (CBD) Influence the Acute Effects of delta-9- Tetrahydrocannabinol (\u03949-THC) in Humans? A Systematic Review","author":"Freeman","year":"2019"},{"issue":"9","key":"10.1016\/j.neubiorev.2019.09.036_bib0180","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/NMD.0b013e318145a0a9","article-title":"A measure of state persecutory ideation for experimental studies","volume":"195","author":"Freeman","year":"2007","journal-title":"J. Nerv. Ment. Dis."},{"issue":"6","key":"10.1016\/j.neubiorev.2019.09.036_bib0185","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/add.14525","article-title":"Increasing potency and price of cannabis in Europe, 2006\u201316","volume":"114","author":"Freeman","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0190","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1136\/bmj.l1141","article-title":"Medicinal use of cannabis based products and cannabinoids","volume":"365","author":"Freeman","year":"2019","journal-title":"Br. Med. J."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0195","article-title":"\u2018Standard THC Units\u2019: a proposal to standardise dose across all cannabis products and methods of administration","author":"Freeman","year":"2019","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.neubiorev.2019.09.036_bib0200","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/add.12634","article-title":"Just say \u2018know\u2019: how do cannabinoid concentrations influence users\u2019 estimates of cannabis potency and the amount they roll in joints?","volume":"109","author":"Freeman","year":"2014","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/ijnp\/pyx082","article-title":"Cannabis dampens the effects of music in brain regions sensitive to reward and emotion","volume":"21","author":"Freeman","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.neubiorev.2019.09.036_bib0210","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J. Am. Chem. Soc."},{"issue":"4","key":"10.1016\/j.neubiorev.2019.09.036_bib0215","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/09595230310001613976","article-title":"Being stoned: a review of self-reported cannabis effects","volume":"22","author":"Green","year":"2003","journal-title":"Drug Alcohol Rev."},{"issue":"4","key":"10.1016\/j.neubiorev.2019.09.036_bib0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1300\/J175v03n04_02","article-title":"A phase I, double blind, three-way crossover study to assess the pharmacokinetic profile of cannabis based medicine extract (CBME) administered sublingually in variant cannabinoid ratios in normal healthy male volunteers (GWPK0215)","volume":"3","author":"Guy","year":"2003","journal-title":"J. Cannabis Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00406-019-00986-2","article-title":"Cannabis use and mental health: risks and benefits","volume":"269","author":"Hall","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.neubiorev.2019.09.036_bib0230","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/npp.2015.367","article-title":"Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis","volume":"41","author":"Haney","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.neubiorev.2019.09.036_bib0235","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1039\/C6NP00074F","article-title":"Phytocannabinoids: a unified critical inventory","volume":"33","author":"Hanu\u0161","year":"2016","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0240","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.brainres.2007.09.090","article-title":"Cannabidiol potentiates pharmacological effects of \u03949-tetrahydrocannabinol via CB1 receptor-dependent mechanism","volume":"1188","author":"Hayakawa","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0245","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.drugalcdep.2015.03.019","article-title":"Non-smoker exposure to secondhand cannabis smoke II: effect of room ventilation on the physiological, subjective, and behavioral\/cognitive effects","volume":"151","author":"Herrmann","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0250","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Br. Med. J."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0255","series-title":"Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0 [updated March 2011] Ed.): the Cochrane Collaboration","author":"Higgins","year":"2008"},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0260","first-page":"29","article-title":"A revised tool for assessing risk of bias in randomized trials","volume":"Vol. 10","author":"Higgins","year":"2016"},{"issue":"3","key":"10.1016\/j.neubiorev.2019.09.036_bib0265","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.euroneuro.2014.11.014","article-title":"Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users","volume":"25","author":"Hindocha","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0270","first-page":"e12762","article-title":"Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme","author":"Hindocha","year":"2019","journal-title":"Addict. Biol."},{"issue":"7","key":"10.1016\/j.neubiorev.2019.09.036_bib0275","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/BF01946311","article-title":"Cannabidiol and cannabinol in man","volume":"29","author":"Hollister","year":"1973","journal-title":"Experientia"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0280","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/cpt197518180","article-title":"Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol","volume":"18","author":"Hollister","year":"1975","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0285","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00213-008-1440-0","article-title":"Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC)","volume":"204","author":"Hunault","year":"2009","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.neubiorev.2019.09.036_bib0290","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1177\/0269881117737400","article-title":"The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group","volume":"32","author":"Hundal","year":"2018","journal-title":"J. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2019.09.036_bib0295","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF01059266","article-title":"Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man","volume":"9","author":"Hunt","year":"1981","journal-title":"J. Pharmacokinet. Biopharm."},{"issue":"1-3","key":"10.1016\/j.neubiorev.2019.09.036_bib0300","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.schres.2015.01.033","article-title":"A systematic review of the antipsychotic properties of cannabidiol in humans","volume":"162","author":"Iseger","year":"2015","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.neubiorev.2019.09.036_bib0305","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93760","article-title":"A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study","volume":"2","author":"Jadoon","year":"2017","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.neubiorev.2019.09.036_bib0310","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/archpsyc.1995.03950190032005","article-title":"Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia","volume":"52","author":"Javitt","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2019.09.036_bib0315","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"J. Pain Symptom Manage."},{"issue":"1-3","key":"10.1016\/j.neubiorev.2019.09.036_bib0320","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2007.08.015","article-title":"Acute effects of \u03949-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity","volume":"97","author":"Juckel","year":"2007","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2019.09.036_bib0325","first-page":"115","article-title":"Comparative studies in man and in laboratory animals on \u03948-and \u03949-trans-Tetrahydrocannabinol","volume":"9","author":"Karniol","year":"1973","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0330","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00428793","article-title":"Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol","volume":"33","author":"Karniol","year":"1974","journal-title":"Psychopharmacologia"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0335","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","article-title":"Cannabidiol interferes with the effects of \u03949-tetrahydrocannabinol in man","volume":"28","author":"Karniol","year":"1974","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0340","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev-neuro-062111-150420","article-title":"Multiple functions of endocannabinoid signaling in the brain","volume":"35","author":"Katona","year":"2012","journal-title":"Annu. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.neubiorev.2019.09.036_bib0345","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.neubiorev.2019.09.036_bib0350","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/15622975.2017.1285049","article-title":"Is there a role for cannabidiol in psychiatry?","volume":"20","author":"Khoury","year":"2019","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0355","series-title":"New Developments in Cannabis Regulation","author":"Kilmer","year":"2017"},{"issue":"4","key":"10.1016\/j.neubiorev.2019.09.036_bib0360","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1037\/h0043688","article-title":"Age differences in short-term retention of rapidly changing information","volume":"55","author":"Kirchner","year":"1958","journal-title":"J. Exp. Psychol."},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0018407","article-title":"Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers","volume":"18","author":"Kleykamp","year":"2010","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.neubiorev.2019.09.036_bib0370","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.neuroimage.2012.07.051","article-title":"Manipulating brain connectivity with \u03b49-tetrahydrocannabinol: a pharmacological resting state FMRI study","volume":"63","author":"Klumpers","year":"2012","journal-title":"Neuroimage"},{"issue":"6","key":"10.1016\/j.neubiorev.2019.09.036_bib0375","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00213-014-3749-1","article-title":"Cannabis and creativity: highly potent cannabis impairs divergent thinking in regular cannabis users","volume":"232","author":"Kowal","year":"2015","journal-title":"Psychopharmacology"},{"issue":"20","key":"10.1016\/j.neubiorev.2019.09.036_bib0380","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1111\/bph.13250","article-title":"Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor","volume":"172","author":"Laprairie","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"19\u201320","key":"10.1016\/j.neubiorev.2019.09.036_bib0385","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1007\/s00213-016-4383-x","article-title":"Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis\u2019 amotivational\u2019 hypotheses","volume":"233","author":"Lawn","year":"2016","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0390","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0091-3057(00)00201-X","article-title":"Different effects of Nabilone and cannabidiol on binocular depth inversion in man","volume":"66","author":"Leweke","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"9","key":"10.1016\/j.neubiorev.2019.09.036_bib0395","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tics.2006.07.006","article-title":"Remembering the time: a continuous clock","volume":"10","author":"Lewis","year":"2006","journal-title":"Trends Cogn. Sci."},{"issue":"7","key":"10.1016\/j.neubiorev.2019.09.036_bib0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"issue":"7","key":"10.1016\/j.neubiorev.2019.09.036_bib0405","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.neubiorev.2019.09.036_bib0410","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0415","series-title":"Sample Sizes for Clinical, Laboratory and Epidemiology Studies","author":"Machin","year":"2018"},{"issue":"6","key":"10.1016\/j.neubiorev.2019.09.036_bib0420","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1017\/S0033291708004741","article-title":"Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis","volume":"39","author":"Mason","year":"2009","journal-title":"Psychol. Med."},{"issue":"1-3","key":"10.1016\/j.neubiorev.2019.09.036_bib0425","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.schres.2008.02.020","article-title":"The psychotomimetic states inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis","volume":"103","author":"Mason","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0430","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/bmj.l574","article-title":"WHO proposes rescheduling cannabis to allow medical applications","volume":"364","author":"Mayor","year":"2019","journal-title":"Br. Med. J."},{"issue":"5","key":"10.1016\/j.neubiorev.2019.09.036_bib0435","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3758\/BF03203313","article-title":"An automated version of the digit symbol substitution test (DSST)","volume":"14","author":"McLeod","year":"1982","journal-title":"Behav. Res. Methods Instrum."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0440","series-title":"Handbook of Cannabis","first-page":"280","article-title":"Non-phytocannabinoid constituents of cannabis and herbal synergy","author":"McPartland","year":"2014"},{"issue":"S1","key":"10.1016\/j.neubiorev.2019.09.036_bib0445","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J. Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.neubiorev.2019.09.036_bib0450","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1192\/bjp.bp.107.046649","article-title":"Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis","volume":"192","author":"Morgan","year":"2008","journal-title":"Br. J. Psychiatry"},{"issue":"181","key":"10.1016\/j.neubiorev.2019.09.036_bib0455","article-title":"Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function","volume":"8","author":"Morgan","year":"2018","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2019.09.036_bib0460","doi-asserted-by":"crossref","first-page":"e738","DOI":"10.1038\/tp.2015.219","article-title":"AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers","volume":"6","author":"Morgan","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"9","key":"10.1016\/j.neubiorev.2019.09.036_bib0465","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/npp.2010.58","article-title":"Cannabidiol attenuates the appetitive effects of \u0394 9-tetrahydrocannabinol in humans smoking their chosen cannabis","volume":"35","author":"Morgan","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neubiorev.2019.09.036_bib0470","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S0033291711001322","article-title":"Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being","volume":"42","author":"Morgan","year":"2011","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.neubiorev.2019.09.036_bib0475","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1192\/bjp.bp.110.077503","article-title":"Impact of cannabidiol on the acute and psychotomimetic effects of smoked cannabis: naturalistic study","volume":"197","author":"Morgan","year":"2010","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0480","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hup.1166","article-title":"Synthetic delta\u20109\u2010tetrahydrocannabinol elicits schizophrenia\u2010like negative symptoms which are distinct from sedation","volume":"26","author":"Morrison","year":"2011","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"issue":"10","key":"10.1016\/j.neubiorev.2019.09.036_bib0485","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1017\/S0033291709005522","article-title":"The acute effects of synthetic intravenous \u03949-tetrahydrocannabinol on psychosis, mood and cognitive functioning","volume":"39","author":"Morrison","year":"2009","journal-title":"Psychol. Med."},{"issue":"6","key":"10.1016\/j.neubiorev.2019.09.036_bib0490","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/01.ftd.0000177223.19294.5c","article-title":"Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract","volume":"27","author":"Nadulski","year":"2005","journal-title":"Ther. Drug Monit."},{"issue":"3","key":"10.1016\/j.neubiorev.2019.09.036_bib0495","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.jcp.0000125688.05091.8f","article-title":"Effect of DELTA-9-Tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults","volume":"24","author":"Nicholson","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"issue":"130","key":"10.1016\/j.neubiorev.2019.09.036_bib0500","article-title":"Does cannabidiol protect against adverse psychological effects of THC?","volume":"4","author":"Niesink","year":"2013","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2019.09.036_bib0505","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1365-2044.2004.03674.x","article-title":"Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34\u2032N of 1\u2032 studies","volume":"59","author":"Notcutt","year":"2004","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0510","doi-asserted-by":"crossref","first-page":"e1002047","DOI":"10.1371\/journal.pbio.1002047","article-title":"Illegal drugs laws: clearing a 50-year-old obstacle to research","volume":"13","author":"Nutt","year":"2015","journal-title":"PLoS Biol."},{"issue":"3","key":"10.1016\/j.neubiorev.2019.09.036_bib0515","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"issue":"2","key":"10.1016\/j.neubiorev.2019.09.036_bib0520","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1476-5381.1972.tb07261.x","article-title":"Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism","volume":"44","author":"Paton","year":"1972","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.neubiorev.2019.09.036_bib0525","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1007\/BF01922823","article-title":"A comparison of the pharmacological activity in man of intravenously administered 1368-11368-11368-1, cannabinol, and cannabidiol","volume":"29","author":"Perez-Reyes","year":"1973","journal-title":"Experientia"},{"issue":"2","key":"10.1016\/j.neubiorev.2019.09.036_bib0530","first-page":"199","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"BJP"},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0535","series-title":"Handbook of Cannabis","first-page":"115","article-title":"Known pharmacological actions of delta-9-tetrahydrocannabinol and of four other chemical constituents of cannabis that activate cannabinoid receptors","author":"Pertwee","year":"2014"},{"issue":"4","key":"10.1016\/j.neubiorev.2019.09.036_bib0540","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/dta.2368","article-title":"Potency of \u03949\u2013tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: implications for public health and pharmacology","volume":"10","author":"Potter","year":"2018","journal-title":"Drug Test. Anal."},{"issue":"4","key":"10.1016\/j.neubiorev.2019.09.036_bib0545","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00213-006-0508-y","article-title":"The acute effects of cannabinoids on memory in humans: a review","volume":"188","author":"Ranganathan","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0550","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pnpbp.2017.06.019","article-title":"Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information","volume":"79","author":"Ranganathan","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neubiorev.2019.09.036_bib0555","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00406-009-0868-5","article-title":"Psychomotor performance in relation to acute oral administration of DELTA9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects","volume":"259","author":"Roser","year":"2009","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"8","key":"10.1016\/j.neubiorev.2019.09.036_bib0560","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.euroneuro.2008.04.008","article-title":"Effects of acute oral delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory p300 event-related potential in healthy volunteers","volume":"18","author":"Roser","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.neubiorev.2019.09.036_bib0565","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.tips.2007.10.006","article-title":"Allosterism and cannabinoid CB1 receptors: the shape of things to come","volume":"28","author":"Ross","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.neubiorev.2019.09.036_bib0570","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"1969","key":"10.1016\/j.neubiorev.2019.09.036_bib0575","article-title":"The case for the entourage effect and conventional breeding of clinical Cannabis: no \u201cStrain,\u201d no gain","volume":"9","author":"Russo","year":"2019","journal-title":"Front. Plant Sci."},{"issue":"8","key":"10.1016\/j.neubiorev.2019.09.036_bib0580","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"issue":"2","key":"10.1016\/j.neubiorev.2019.09.036_bib0585","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","article-title":"A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol","volume":"66","author":"Russo","year":"2006","journal-title":"Med. Hypotheses"},{"issue":"4","key":"10.1016\/j.neubiorev.2019.09.036_bib0590","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00213-002-1348-z","article-title":"Cannabis is more than simply \u0394 9-tetrahydrocannabinol","volume":"165","author":"Russo","year":"2003","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.neubiorev.2019.09.036_bib0595","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0600","first-page":"11","article-title":"The effect of cannabis use on memory function: an update","volume":"4","author":"Schoeler","year":"2013","journal-title":"Subst. Abuse Rehabil."},{"issue":"1-3","key":"10.1016\/j.neubiorev.2019.09.036_bib0605","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.schres.2011.04.017","article-title":"Cannabis with high cannabidiol content is associated with fewer psychotic experiences","volume":"130","author":"Schubart","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0610","doi-asserted-by":"crossref","first-page":"h4283","DOI":"10.1136\/bmj.h4283","article-title":"Bias in randomised controlled trials: comparison of crossover group and parallel group designs","volume":"351","author":"Sedgwick","year":"2015","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.neubiorev.2019.09.036_bib0615","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1523\/JNEUROSCI.5587-06.2007","article-title":"Dissociable intrinsic connectivity networks for salience processing and executive control","volume":"27","author":"Seeley","year":"2007","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.neubiorev.2019.09.036_bib0620","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1177\/0956797611417632","article-title":"False-positive psychology: undisclosed flexibility in data collection and analysis allows presenting anything as significant","volume":"22","author":"Simmons","year":"2011","journal-title":"Psychol. Sci."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0625","first-page":"1","article-title":"A randomised controlled trial of vaporised \u0394 9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects","author":"Solowij","year":"2019","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0630","series-title":"State-Trait Anxiety Inventory","author":"Spielberger","year":"2010"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0635","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neulet.2011.04.003","article-title":"Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential","volume":"496","author":"Stadelmann","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.neubiorev.2019.09.036_bib0640","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41386-018-0282-7","article-title":"\u0394-9-Tetrahydrocannabinol and cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors","volume":"44","author":"Szkudlarek","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.neubiorev.2019.09.036_bib0645","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.neubiorev.2019.09.036_bib0650","doi-asserted-by":"crossref","first-page":"e6598","DOI":"10.1371\/journal.pone.0006598","article-title":"Worth the \u2018EEfRT\u2019? The effort expenditure for rewards task as an objective measure of motivation and anhedonia","volume":"4","author":"Treadway","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neubiorev.2019.09.036_bib0655","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/j.pain.0000000000001464","article-title":"An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia","volume":"160","author":"van de Donk","year":"2019","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.neubiorev.2019.09.036_bib0660","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamapsychiatry.2015.3278","article-title":"Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review","volume":"73","author":"Volkow","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.neubiorev.2019.09.036_bib0665","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1191\/0269215503cr581oa","article-title":"A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms","volume":"17","author":"Wade","year":"2003","journal-title":"Clin. Rehabil."},{"key":"10.1016\/j.neubiorev.2019.09.036_bib0670","doi-asserted-by":"crossref","DOI":"10.1177\/0269881119841568","article-title":"Dissociable effects of cannabis with and without cannabidiol on the human brain\u2019s resting-state functional connectivity","author":"Wall","year":"2019","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.neubiorev.2019.09.036_bib0675","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/jcph.1387","article-title":"A review of human studies assessing cannabidiol\u2019s (CBD) therapeutic actions and potential","volume":"59","author":"White","year":"2019","journal-title":"J. Clin. Pharmacol."},{"issue":"24","key":"10.1016\/j.neubiorev.2019.09.036_bib0680","first-page":"2456","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.neubiorev.2019.09.036_bib0685","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/01688638908400940","article-title":"The development and validation of a test battery for detecting and monitoring everyday memory problems","volume":"11","author":"Wilson","year":"1989","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"3","key":"10.1016\/j.neubiorev.2019.09.036_bib0690","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1590\/S1516-44462008000300015","article-title":"Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action","volume":"30","author":"Zuardi","year":"2008","journal-title":"Braz. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.neubiorev.2019.09.036_bib0695","first-page":"213","article-title":"Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteers","volume":"26","author":"Zuardi","year":"1993","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"3","key":"10.1016\/j.neubiorev.2019.09.036_bib0700","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.neubiorev.2019.09.036_bib0705","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/0269881108089581","article-title":"Effect of intrapulmonary tetrahydrocannabinol administration in humans","volume":"22","author":"Zuurman","year":"2008","journal-title":"J. Psychopharmacol."}],"container-title":["Neuroscience & Biobehavioral Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763419305615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149763419305615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T09:47:55Z","timestamp":1758966475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149763419305615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":141,"alternative-id":["S0149763419305615"],"URL":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.09.036","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736705431.793566570","asserted-by":"object"}]},"ISSN":["0149-7634"],"issn-type":[{"value":"0149-7634","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review","name":"articletitle","label":"Article Title"},{"value":"Neuroscience & Biobehavioral Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neubiorev.2019.09.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}